Thanks for the feedback. You're right—the PMC7457601 is a preprint, not fully peer-reviewed. A related peer-reviewed study on spike-NRP1 binding: https://t.co/R51CyBksaz (Pain, 2021). The Frontiers review is peer-reviewed (Apr 2024). The LNP article (Tre…
RT @NewDealEU: #IBD patients need to constantly medicate 💊, so studies like this one from @BMJ_gut on how their treatments combine with COV…
RT @NewDealEU: #IBD patients need to constantly medicate 💊, so studies like this one from @BMJ_gut on how their treatments combine with COV…
#IBD patients need to constantly medicate 💊, so studies like this one from @BMJ_gut on how their treatments combine with COVID-19 are truly necessary 🙌 Read the full article here: https://t.co/pdElPQCmUw https://t.co/M9eHoF95lY
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
@PJWestlake @Gut_BMJ @DHSCgovuk That's an interesting perspective. The first relevant publication on their list suggests increased risk. https://t.co/AahL51TTBc
Effect of IBD medications on COVID-19 outcomes: results from an international registry https://t.co/LYYOlUqAJY
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
RT @charlie_lees: Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. C…
Free to read https://t.co/g4p5jKNiz9 and now in print in the latest @Gut_BMJ with Peter Irving and Laurent Beaugerie. Commentary on https://t.co/xpufSk7T36 The @CrohnsColitisUK information page on COVID-19 and IBD is an excellent resource for patient…
SECURE-IBD data of COVID19 and IBD medications 👇
RT @Gut_BMJ: #GUTCover for April 2021, chosen by @emadelomar is Bow bridge, Central Park, New York City. Read in this issue the important p…
RT @Gut_BMJ: #GUTCover for April 2021, chosen by @emadelomar is Bow bridge, Central Park, New York City. Read in this issue the important p…
RT @Gut_BMJ: #GUTCover for April 2021, chosen by @emadelomar is Bow bridge, Central Park, New York City. Read in this issue the important p…
#GUTCover for April 2021, chosen by @emadelomar is Bow bridge, Central Park, New York City. Read in this issue the important paper by @ryanungaro et al examining the effect of #IBD medications on #COVID-19 outcomes - read the paper here: https://t.co/rK…
Koronalääkettä (1030387,50 €/L)? #xmabit #laumasuoja #paritus #kulttuurit *https://t.co/01X1iZajqP *https://t.co/1AWjaWQzCZ *https://t.co/xiJSz4Uzec *https://t.co/9PTprTinuZ
RT @birdgroup_be: Data are accumulating that immunosuppresive therapy is a risk for severe course of #COVID19. Patients with #IBD should be…
RT @birdgroup_be: Data are accumulating that immunosuppresive therapy is a risk for severe course of #COVID19. Patients with #IBD should be…
As a rule all #IMID patients (immune mediated. inflammatory diseases) should be in priority risk group 1b There is a clear, quick sollution. Allow physicians to make a prescription for these patients. With this prescription reservation should be possibl…
Data are accumulating that immunosuppresive therapy is a risk for severe course of #COVID19. Patients with #IBD should be in priority risk group 1b of the Belgian #vaccination strategy. @wbeke @DirkRamaekers @ccv_vzw @DeClercqLuc @PedroFacon @FAGG_be …
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
New2Trip: Effect of IBD medications on COVID-19 outcomes: results from international registry https://t.co/Mk7O856tbw
@IBDMD @IBDMD but in a later study the same authors conclude: "Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19" https://t.co/usjQ5BN8di The earlier study you cite had less data to draw on. Help! I'm conf…
RT @AnjaStClairJone: Great resource for advising pts during 2nd wave.
Great resource for advising pts during 2nd wave.
RT @UKCPAGastro: New findings on the risk of developing severe COVID when prescribed medication for IBD. #Pharmacists working within IBD ho…
Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19
RT @UKCPAGastro: New findings on the risk of developing severe COVID when prescribed medication for IBD. #Pharmacists working within IBD ho…
RT @UKCPAGastro: New findings on the risk of developing severe COVID when prescribed medication for IBD. #Pharmacists working within IBD ho…
New findings on the risk of developing severe COVID when prescribed medication for IBD. #Pharmacists working within IBD how will this change your practice? https://t.co/qDNH5IHdwN
New2Trip: Effect of IBD medications on COVID-19 outcomes: results from international registry https://t.co/Mk7O856tbw
It requires confirmation, but it must keep us on our toes. In patients with IBD, compared with TNF monotherapy, thiopurine monotherapy and the combination thiopurines with TNF antagonists are associated with significantly increased risk of severe COVID-…
国際登録に関する観察研究：#IBD 薬と #COVID19 の結果との関連 併用療法とチオプリンは、重度のCOVID19のリスク増加と関連している可能性があります。
Effect of IBD medications on COVID-19 outcomes: results from an international registry https://t.co/2644cnStI6
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @BrunoSilva_MD: Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19. https://t.co/50wYhbmxfU
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @Flaviostein: Effect of IBD medications on COVID-19 outcomes: results from an international registry | Gut. Important publication from…
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
Seguimos aprendiendo de COVID y IBD. Muy buenos datos del @SecureIBD 👏🏽👏🏽👏🏽
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
RT @DrChrisLamb: Updated and expanded analysis from @ryanungaro and the @SecureIBD team on effect of IBD medications and COVID-19 outcomes.…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @P_DeepakIBDMD: Thiopurine monotherapy and when combined with anti-TNFs may be associated with a 4-fold increased risk of severe COVID-1…
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
Tratamento das DIIs x COVID 19 e desfechos! Ótimo artigo!
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19. https://t.co/50wYhbmxfU
RT @P_DeepakIBDMD: Thiopurine monotherapy and when combined with anti-TNFs may be associated with a 4-fold increased risk of severe COVID-1…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
Interesting findings on thiopurines and severe #COVID risk.
RT @DrChrisLamb: Updated and expanded analysis from @ryanungaro and the @SecureIBD team on effect of IBD medications and COVID-19 outcomes.…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @DrChrisLamb: Updated and expanded analysis from @ryanungaro and the @SecureIBD team on effect of IBD medications and COVID-19 outcomes.…
Thiopurine monotherapy and when combined with anti-TNFs may be associated with a 4-fold increased risk of severe COVID-19. Congratulations on this clinicaly impactful manuscript !! @ryanungaro @JeanFredericCo1 @SecureIBD
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @DrChrisLamb: Updated and expanded analysis from @ryanungaro and the @SecureIBD team on effect of IBD medications and COVID-19 outcomes.…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @Flaviostein: Effect of IBD medications on COVID-19 outcomes: results from an international registry | Gut. Important publication from…
RT @SecureIBD: Our analysis on the effect of IBD medications on #COVID19 outcomes is now online! @ryanungaro @JeanFredericCo1 @EJBrenner_…
RT @DrChrisLamb: Updated and expanded analysis from @ryanungaro and the @SecureIBD team on effect of IBD medications and COVID-19 outcomes.…
RT @ryanungaro: New analyses from SECURE registry. Main comparisons on mono anti-TNF vs mono thiopurine vs combination therapy. Also more o…
RT @DrChrisLamb: Updated and expanded analysis from @ryanungaro and the @SecureIBD team on effect of IBD medications and COVID-19 outcomes.…
RT @Flaviostein: Effect of IBD medications on COVID-19 outcomes: results from an international registry | Gut. Important publication from…